GLP1R and obesity due to melanocortin 4 receptor deficiency: Whether GLP-1 RA prevent new-onset HF in Type 2 diabetes or obesity requires further investigation.<h4>Methods</h4>We performed an updated meta-analysis of randomized placebo-controlled trials (RCT) of treatment with GLP-1 RA in participants without HF.